Vitamin D deficiency is a risk factor for obesity and diabetes type 2 in women at late reproductive age

Aging

Volumn 5, Issue 7, 2013, Pages 575-581

  Grineva, E N ^a   Karonova, T ^a,b   Micheeva, E ^b   Belyaeva, O ^b   Nikitina, I L ^a  

^a ALMAZOV NATIONAL MEDICAL RESEARCH CENTRE   (Russian Federation)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Diabetes mellitus type2; Obesity; Overweight; Vitamin D deficiency

Indexed keywords

EID: 84881097719     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100582     Document Type: Article

References (45)

1. Adams JS, Hewison M. Update in vitamin D.J Clin Endocrinol.& Metab. 2010; 95: 471-478.
2. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Pro. 2006; 81: 353-373.
3. Barton D. Vitamin D. 2008. www.cancernetwork.com/display /article.
4. Heaney RP. Vitamin D in health and disease. Clin J Am Soc Nephrol. 2008; 3: 1535-1541.
5. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis. J Clin Endocrinol & Metab. 2007; 92: 2017-2029.
6. Bikle D. Nonclassic Actions of Vitamin D.J Clin Endocrinol & Metab. 2008; 94: 26-34.
7. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Vertuyf A, Luderer HF, Liebeb L, Demay M. Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice. Endocrine Reviews. 2008; 29: 726-776.
8. Holick MF. Vitamin D Deficiency. New Engl J Med. 2007; 357: 266-281.
9. De Paula FJA, Rosen CJ. Vitamin D and fat In Vitamin D, edn 3, ch V, pp 769-776. Eds D Feldman, JW Pike, JS Adams. Academic Press, 2011.
10. Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension. 2008; 52: 828-832.
11. Chiu KC, Chu A, Go VLW, Saad M. Hypovitaminosis D is associated with insulin resistance and β cell dysfunction. Am J Clin Nutr. 2004; 79: 820-825.
12. Reis JP, von Muhlen D, Miller IR, Michos ED, Appel LJ. Vitamin D Status and Cardiometabolic Risk Factors in the United States Adolescent Population. Pediatrics. 2009; 124: 371-379.
13. Dietary supplement Fact Sheet: Vitamin D. Office of Dietary supplements. National Institutes of Health, Maryland, USA 2009 http:/dietary-supplements.info.nih.gov./factsheets/vitamin.asp
14. McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutrition Journal. 2008; 7: 1-5.
15. Pinelli N, Jaber L, Brown M, Herman W. Serum 25-hydroxy vitamin D and insulin resistentance, metabolic syndrome, and glucose intolerance among arab americancans. Diabetes Care. 2010; 6: 1371-1375.
16. Arunabh S, Pollack S, Yen J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol & Metab. 2003; 88: 157-161.
17. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, Yanovski A. The relationship between obesity and serum 1,25-dihydroxyvitamin D concentrations in healthy adults. J Clin Endocrinol & Metab. 2004; 89: 1196-1199.
18. Leblanc ES, Rizzo JH, Pedula KL, Ensrud KE, Cauley J, Hochberg M, Hillier TA. Associasions between 25-hydroxyvitamin D and weight gain in elderly women. Journal of Women Health. 2012; 21 DOI:10.1089/jwh.2012.3506.
19. Sun X, Zemel MB. 1Alpha,25-dihydroxyvitamin D and corticosteroid regulate adipocyte nuclear vitamin D receptor. int J Obes (Lond). 2008; 32: 1305-1311.
20. Gulseth HL, Gjelstad IMF, Tierney AC, Lovengrove JA, Defoort C, Blaak EE, Lopez-Miranda J, Kiec-Wilk B, Ris U, Roshe H, Drevon CA, Birkeland KI. Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome. Diabetes Care. 2010; 33: 923-925.
21. Kositsawat J, Freeman V, Gebber B, Geraci S. Association of A1c levels with vitamin D status in U.S. Adults. Diabetes Care. 2010; 33: 1236-1238.
22. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC,Manson JE, Hu FB. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care. 2006; 29: 650-656.
23. Hypponen E, Power C. Vitamin D status and glucose homeostasis in the 1958 British bird cohort: The role of obesity. Diabetes Care. 2006; 29: 2244-2246.
24. Ljunghall S, Lind L, Lithell H, Skarfors E, Selinus I, Sorensen OH, Wide L. Treatment with one-alpha-hydroxycholecalciferol in middle-age men with impaired glucose tolerance-a prospective randomized double-blind study. Acta Med Scand. 1987; 222: 361-367.
25. Robinson JG, Manson JE, Larson J, Liu S, Song Y, Howard BV, Phillips L, Shikany JM, Allison M, Curb JD, Johnos KC, Watts N. Lack of association between 25(OH)D levels and incident type 2 diabetes in older women. Diabets Care. 2011; 34: 628-634.
26. International Diabetes Federation. Worldwide definition of the metabolic syndrome. Available at: http://www.idf.org/webdata/docs/IDF_Metasyndrome_difinition.pdf. Accessed August 24, 2005.
27. Yetley EA. Assessing the vitamin D status of the US population. Am J Clin Nutr. 2008; 88: 558-564.
28. Ivashikina TM, Kotova TN, Khlekhlina IuV, Ermakov AI, Berestovskaia VS. The detection of vitamin D3 deficiency in preschoolers and schoolchildren of Moscow and St.Petersburg. Klin Lab Diag. 2011; 11: 22-24.
29. Bakhtiyarova S, Lecnyak O, Kyznesova N, Blankenstein MA, Lips P. Vitamin D status among patients with hip fracture and elderly control subjects in Yekaterinburg, Russia. Osteoporos Int. 2006; 17: 441-6.
30. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000; 72: 690-693.
31. Blum M, Dolnikowski G, Seyoum E, Susan SH. Vitamin D(3) in fat tissue. Endocrine Reviews. 2008: 33: 90-94.
32. Pepe J, Romagnoli E, Nofroni I, Pacitti MT, De Geronimo S, Letizia C, Tonnarini G, Scarpiello A, D'Erasmo E, Minisola S. Vitamin D status as a major factor determining the circulating level of parathyroid hormone: A study in normal subjects. Osteoporosis Int. 2005; 16: 805-812.
33. Gunther CW, Legowski PA, Lyle RM, Weaver CM, McCAbe LD, Peacock M, Teegarden D. Parathyroid hormone is associated with decreased fat mass in young healthy women. International Journal of Obesity. 2006; 30: 94-99.
34. Reis JP, Muhlen D, Miller E.D. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol. 2008; 159: 41-48.
35. Yach D, Struckler D, Brownell KD. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med. 2006; 12: 62-66.
36. Manson JE, Skerrett PJ, Greenland P, Vanltallie TB. The escalating pandemic of obesity and sedentary lifestyle. A call to action for clinicians. Arch Intern Med. 2004; 164: 249-258.
37. Solomon CG, Manson JE. Obesity and mortality: a review of the epidemiological data. Am J Clin Nutr. 1997; 66: 1044S-1050S.
38. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Matab. 2007; 92: 2017-2019.
39. Pittas AG, Sun Q, Manson JE, Dawson-Hughes B, Hu FB. Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care. 2010; 33: 2021-2023.
40. Forouhi NG, Ye Z, Rickard AP, Khaw KT, Luben R, Langenberg C, Wareham NJ. Circulating 25-hydroxyvitami D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and update meta-analysis of prospective studies. Diabetologia. 2012; 55: 2173-2182.
41. WHO Expert Consultation. Appropriate body-mass index for Asian population and its implications for policy and intervebtion strategies. Lancet. 2004; 363: 157-163.
42. Hans D, Genton L, Conicella G, Karsegard V, Pichard C, Slosman D. Half-body DXA scan predicts whole body composition: a potential method to measure overweight patients. Clin Nutr. 2001; 20: 1.
43. Kelly T, Wilson K, Heymsfield S. Dual Energy X-ray absorbtiometry body composition reference values from NHANES. PloS ONE 2009; 4: e7038.
44. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and insulin beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-419.
45. Gutt M, Davis CL, Spitzer SB, Llabre MED MER, Kumar M, Czarnecki EM, Schneiderman N, Skyler JS, Marks JB. Validation of insulin sensitivity index (ISI(0,120)): comparison with other measure. Diabetes Res Clin Pract. 2000; 47: 177-184.